IT8024347A0 - THE APPLICATION OF 4-ARILQUINAZOLIN-2(1H)-ONI FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES. - Google Patents

THE APPLICATION OF 4-ARILQUINAZOLIN-2(1H)-ONI FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES.

Info

Publication number
IT8024347A0
IT8024347A0 IT8024347A IT2434780A IT8024347A0 IT 8024347 A0 IT8024347 A0 IT 8024347A0 IT 8024347 A IT8024347 A IT 8024347A IT 2434780 A IT2434780 A IT 2434780A IT 8024347 A0 IT8024347 A0 IT 8024347A0
Authority
IT
Italy
Prior art keywords
arilquinazolin
oni
treatment
application
autoimmune diseases
Prior art date
Application number
IT8024347A
Other languages
Italian (it)
Other versions
IT1141027B (en
Inventor
Skrifvars Bo Viktor
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8024347A0 publication Critical patent/IT8024347A0/en
Application granted granted Critical
Publication of IT1141027B publication Critical patent/IT1141027B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT24347/80A 1979-08-30 1980-08-28 THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES IT1141027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH787179 1979-08-30

Publications (2)

Publication Number Publication Date
IT8024347A0 true IT8024347A0 (en) 1980-08-28
IT1141027B IT1141027B (en) 1986-10-01

Family

ID=4331669

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24347/80A IT1141027B (en) 1979-08-30 1980-08-28 THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES

Country Status (5)

Country Link
JP (1) JPS5636418A (en)
AU (1) AU545003B2 (en)
BE (1) BE884935A (en)
IT (1) IT1141027B (en)
PH (1) PH16864A (en)

Also Published As

Publication number Publication date
BE884935A (en) 1981-02-27
IT1141027B (en) 1986-10-01
JPS5636418A (en) 1981-04-09
PH16864A (en) 1984-03-22
AU6183680A (en) 1981-03-19
AU545003B2 (en) 1985-06-27

Similar Documents

Publication Publication Date Title
NL188078C (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEART ARRHYTMIES AND MYOCARDIAL DISORDERS.
BG94738A (en) USE OF IODINE SOLUTION FOR THE TREATMENT OF IODINE DEFICIENCY DISEASES
IT8009551A0 (en) E-5-(2-HALOGENOVINIL-)-2'DEOXYCYTIDINES, THEIR METHOD OF PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
IT7868765A0 (en) PROCEDURE FOR THE PREPARATION OF 1,2-DIHYDRO-3H-PYRROLE [1,2-A]-PYRROL-1-CARBOXYLIC ACIDS
IT8348294A0 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CARDIOCULATORY DISEASES AND PREPARATION PROCEDURE
FI891986A7 (en) Pharmaceutical compositions for the treatment of psoriasis
IT8023649A0 (en) PROCEDURE FOR IMPROVING THE PROPERTIES OF ALLOYS.
IT7950138A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PARKINSONIA
IT8721115A0 (en) PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES.
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
IT1210935B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
FR2558372B1 (en) DRUG COMPOSITION FOR THE TREATMENT OF ACNE
NO913117L (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
FI904726A7 (en) Use of alkylphosphoric acid compounds for the control of dandruff diseases
IT1125604B (en) PROCEDURE FOR THE PREPARATION OF N-FENIL-N'-ALCHILFENILENDIAMMINE
IT7950378A0 (en) THERAPEUTIC MIND HETEROCYCLIC COMPOUNDS VALUABLE IN THE TREATMENT OF AUTOIMMUNE DISEASES
DE3866653D1 (en) COMPOSITION FOR THE TREATMENT OF EPIDERMIS.
IT8024347A0 (en) THE APPLICATION OF 4-ARILQUINAZOLIN-2(1H)-ONI FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES.
FI925546A7 (en) Amide-linked pyridylic acid derivatives for the treatment of leukotriene-related diseases
BE865480A (en) PROCESS FOR THE PREPARATION OF NAPHTYLAMINOHYDROXYSULPHONIC ACIDS
IT7823886A0 (en) COMPOSITION FOR THE TREATMENT OF ALLERGIC DISEASES.
IT8721945A0 (en) PROCEDURE FOR THE FRAGRANCE OF BOOKS, DEVICE FOR THE IMPLEMENTATION OF SAID PROCEDURE
ATE5372T1 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE CIRCULATORY ORGANS.
IT1123731B (en) PROCEDURE FOR THE PREPARATION OF 1,2,3-TIADIAZOL-5-IL-UREE
RO79181A (en) PROCESS FOR THE PREPARATION OF 4'-NITROBENZYL-7-PENOXYACETAMIDO-3-HYDROXY-3-CEFEM-4-CARBOXYLATE SOLUTION